Applying Liquid Skin Barrier Film to Prevent Skin Complications Around Indwelling Vascular Catheters in Pediatric Patients: a Randomized Controlled Trial

January 17, 2025 updated by: National Taiwan University Clinical Trial Center, National Taiwan University Hospital
Long-term indwelling vascular catheters including central venous catheters, peripherally inserted central venous catheters, arterial catheters are often essential for medical care. During the routine care, some patients may experience skin damage around the catheter insertion site due to allergic reactions to the catheter dressing material, physical damage during dressing changes, leading to infection, prolonged hospitalization, and unexpected medical costs. If the condition is mild, it may increase the number of dressing changes. In severe cases, it may require changing to a different dressing method, using medication, or even removing the indwelling catheter. This study investigates the efficacy of liquid skin barrier film in preventing skin damage around long-term indwelling vascular catheters. In this randomized controlled trial, the participants aged 0 to less than 18 years who has long-term indwelling vascular catheters inserted at National Taiwan University Hospital Yunlin Branch will be recruited. At the time of indwelling vascular catheter insertion, the subjects are randomly assigned to the control group or the experimental group. The control group received standard care according to the hospital's guidelines, using a sterile transparent dressing or gauze to cover the catheter insertion site. The experimental group first applied liquid skin barrier film to the skin, then applied a sterile transparent dressing or gauze to cover the catheter insertion site. The patients are followed for two weeks. The primary endpoint is the need for change of dressing, use of medication, or removal of the catheter due to skin damage around the catheter insertion site. The secondary endpoints are skin breakdown, number of dressing changes, and incidence of bloodstream infection. It is expected that the research results may change the standard clinical management of long-term indwelling vascular catheters.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Yunlin
      • Douliu, Yunlin, Taiwan, 640
        • National Taiwan University Hospital Yunlin Branch

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age 0-17 years (less than 18 years old)
  • Receiving a central venous catheter, peripherally inserted central catheter, or arterial line insertion

Exclusion Criteria:

  • The skin around the catheter insertion site is not inact
  • Known allergic to liquid skin barrier film

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Without skin barrier film
Routine care without skin barrier film around the insertion site of a vascular indwelling catheter
Experimental: With skin barrier film
Routine care with preventive use of skin barrier film around the insertion site of a vascular indwelling catheter
Preventive use of skin barrier film after insertion of a vascular indwelling catheter before covering with transparent dressing +/- gauze

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of dressing method
Time Frame: 0-14 days
Change of dressing method due to injury/allergy of skin around the vascular indwelling catheters
0-14 days
Medical treatment for the skin
Time Frame: 0-14 days
Need of medical treatment (topical, oral, intravenous) due to injury/allergy of skin around the vascular indwelling catheters
0-14 days
Vascular indwelling catheter removal
Time Frame: 0-14 days
Need of catheter removal due to injury/allergy of skin around
0-14 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Occurrence of skin injury/allergy
Time Frame: 0-14 days
Skin injury/allergy of the skin around the vascular indwelling catheter
0-14 days
Pain degree/severity of the skin
Time Frame: 0-14 days
Pain degree of the skin around the vascular indwelling catheter
0-14 days
Number of dressing changes
Time Frame: 0-14 days
Total number of dressing changes of the vascular indwelling catheter
0-14 days
Catheter-related bloodstream infection
Time Frame: 0-14 days
Occurrence of catheter-related bloodstream infection
0-14 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hīng-Ka Lîm, MD, PhD, National Taiwan University Hospital Yunlin Branch
  • Principal Investigator: Ching-Ching Yang, RN, National Taiwan University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2024

Primary Completion (Actual)

December 31, 2024

Study Completion (Actual)

December 31, 2024

Study Registration Dates

First Submitted

December 20, 2023

First Submitted That Met QC Criteria

December 20, 2023

First Posted (Actual)

January 5, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 17, 2025

Last Verified

December 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 202310113DIND
  • NTUHYL 113-X015 (Other Grant/Funding Number: National Taiwan University Hospital Yunlin Branch)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Skin Injury

Clinical Trials on Skin barrier film

Subscribe